{"id":"https://openalex.org/W2884658673","doi":"https://doi.org/10.2174/1871525716666180724115132","title":"Thromboxane A Synthase: A New Target for the Treatment of Cardiovascular Diseases","display_name":"Thromboxane A Synthase: A New Target for the Treatment of Cardiovascular Diseases","publication_year":2018,"publication_date":"2018-07-24","ids":{"openalex":"https://openalex.org/W2884658673","doi":"https://doi.org/10.2174/1871525716666180724115132","mag":"2884658673","pmid":"https://pubmed.ncbi.nlm.nih.gov/30039765"},"language":"en","primary_location":{"id":"doi:10.2174/1871525716666180724115132","doi":"https://doi.org/10.2174/1871525716666180724115132","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1871525716666180724115132","pdf_url":null,"source":{"id":"https://openalex.org/S2764933655","display_name":"Cardiovascular & Hematological Agents in Medicinal Chemistry","issn_l":"1871-5257","issn":["1871-5257","1875-6182"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","medline","norway-1","poland-20","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular & Hematological Agents in Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087211020","display_name":"\u041c\u0435\u0441\u0438\u0442\u0441\u043a\u0430\u044f \u0414\u0438\u043d\u0430\u0440\u0430 \u0424\u0435\u0440\u0430\u0442\u043e\u0432\u043d\u0430","orcid":"https://orcid.org/0000-0003-3541-6041","observed_orcids":["https://orcid.org/0000-0003-3541-6041"]},"institutions":[{"id":"https://openalex.org/I17877952","display_name":"Sechenov University","ror":"https://ror.org/02yqqv993","country_code":"RU","type":"education","lineage":["https://openalex.org/I17877952"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Dinara F. Mesitskaya","raw_affiliation_strings":["Sechenov First Moscow State Medical University, Moscow, Russian Federation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sechenov First Moscow State Medical University, Moscow, Russian Federation","institution_ids":["https://openalex.org/I17877952"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061896314","display_name":"Syrkin Al","orcid":"https://orcid.org/0000-0002-9602-292X","observed_orcids":["https://orcid.org/0000-0002-9602-292X","https://orcid.org/0000-0002-6452-1222"]},"institutions":[{"id":"https://openalex.org/I17877952","display_name":"Sechenov University","ror":"https://ror.org/02yqqv993","country_code":"RU","type":"education","lineage":["https://openalex.org/I17877952"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Abram L. Syrkin","raw_affiliation_strings":["Sechenov First Moscow State Medical University, Moscow, Russian Federation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sechenov First Moscow State Medical University, Moscow, Russian Federation","institution_ids":["https://openalex.org/I17877952"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015240896","display_name":"\u041c. \u0413. \u0410\u043a\u0441\u0435\u043d\u043e\u0432\u0430","orcid":"https://orcid.org/0000-0001-9215-6210","observed_orcids":["https://orcid.org/0000-0001-9215-6210"]},"institutions":[{"id":"https://openalex.org/I4405263717","display_name":"Federal State Budgetary Institution \"Centre for Strategic Planning and Management of Biomedical Health Risks\" of the Federal Medical and Biological Agency","ror":"https://ror.org/059yv9j77","country_code":"RU","type":"government","lineage":["https://openalex.org/I4405263717","https://openalex.org/I64264942"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Marina G. Aksenova","raw_affiliation_strings":["Centre for the Strategic Planning and Management of Medical and Biological Health Risks, Moscow, Russian Federation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for the Strategic Planning and Management of Medical and Biological Health Risks, Moscow, Russian Federation","institution_ids":["https://openalex.org/I4405263717"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100419828","display_name":"Yong Zhang","orcid":"https://orcid.org/0000-0002-8754-8938","observed_orcids":["https://orcid.org/0000-0002-8754-8938","https://orcid.org/0000-0003-3626-3243"]},"institutions":[{"id":"https://openalex.org/I156144747","display_name":"Harbin Medical University","ror":"https://ror.org/05jscf583","country_code":"CN","type":"education","lineage":["https://openalex.org/I156144747"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yong Zhang","raw_affiliation_strings":["Harbin Medical University, Harbin, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Harbin Medical University, Harbin, China","institution_ids":["https://openalex.org/I156144747"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027876593","display_name":"Andrey A. Zamyatnin","orcid":"https://orcid.org/0000-0002-3046-4565","observed_orcids":["https://orcid.org/0000-0002-3046-4565"]},"institutions":[{"id":"https://openalex.org/I17877952","display_name":"Sechenov University","ror":"https://ror.org/02yqqv993","country_code":"RU","type":"education","lineage":["https://openalex.org/I17877952"]}],"countries":["RU"],"is_corresponding":true,"raw_author_name":"Andrey A. Zamyatnin Jr.","raw_affiliation_strings":["Sechenov First Moscow State Medical University, Moscow, Russian Federation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sechenov First Moscow State Medical University, Moscow, Russian Federation","institution_ids":["https://openalex.org/I17877952"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018273502","display_name":"F. Yu. Kopylov","orcid":"https://orcid.org/0000-0002-4535-8685","observed_orcids":["https://orcid.org/0000-0002-4535-8685"]},"institutions":[{"id":"https://openalex.org/I17877952","display_name":"Sechenov University","ror":"https://ror.org/02yqqv993","country_code":"RU","type":"education","lineage":["https://openalex.org/I17877952"]}],"countries":["RU"],"is_corresponding":true,"raw_author_name":"Philipp Y. Kopylov","raw_affiliation_strings":["Sechenov First Moscow State Medical University, Moscow, Russian Federation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sechenov First Moscow State Medical University, Moscow, Russian Federation","institution_ids":["https://openalex.org/I17877952"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5018273502","https://openalex.org/A5027876593"],"corresponding_institution_ids":["https://openalex.org/I17877952"],"apc_list":null,"apc_paid":null,"fwci":0.8063,"has_fulltext":false,"cited_by_count":16,"citation_normalized_percentile":{"value":0.68167675,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"16","issue":"2","first_page":"81","last_page":"87"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.3955000042915344,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.3955000042915344,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","score":0.3928000032901764,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.15299999713897705,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/thromboxane-synthase","display_name":"thromboxane synthase","score":0.9200000166893005},{"id":"https://openalex.org/keywords/thromboxane-a2","display_name":"thromboxane A2","score":0.9269999861717224},{"id":"https://openalex.org/keywords/thromboxane-a2-receptor","display_name":"thromboxane A2 receptor","score":0.9580000042915344},{"id":"https://openalex.org/keywords/atherothrombosis","display_name":"atherothrombosis","score":0.9440000057220459},{"id":"https://openalex.org/keywords/cardiovascular-disease","display_name":"cardiovascular disease","score":0.925000011920929},{"id":"https://openalex.org/keywords/thromboxane-synthase-inhibitor","display_name":"thromboxane synthetase inhibitor","score":0.8579999804496765},{"id":"https://openalex.org/keywords/pharmacogenetics","display_name":"pharmacogenetics","score":0.9789999723434448},{"id":"https://openalex.org/keywords/prostaglandins","display_name":"prostaglandins","score":0.9190000295639038},{"id":"https://openalex.org/keywords/therapeutic-target","display_name":"therapeutic target","score":0.597000002861023}],"concepts":[{"id":"https://openalex.org/C173202427","wikidata":"https://www.wikidata.org/wiki/Q408575","display_name":"Thromboxane-A synthase","level":4,"score":0.9386324882507324},{"id":"https://openalex.org/C51603380","wikidata":"https://www.wikidata.org/wiki/Q411978","display_name":"Thromboxane receptor","level":4,"score":0.7803720235824585},{"id":"https://openalex.org/C2776785769","wikidata":"https://www.wikidata.org/wiki/Q412212","display_name":"Thromboxane","level":3,"score":0.72496098279953},{"id":"https://openalex.org/C2781024287","wikidata":"https://www.wikidata.org/wiki/Q774909","display_name":"Thromboxane A2","level":3,"score":0.6127822399139404},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5549498200416565},{"id":"https://openalex.org/C170734499","wikidata":"https://www.wikidata.org/wiki/Q1152227","display_name":"Pharmacogenomics","level":2,"score":0.5068941712379456},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.47921615839004517},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.43031755089759827},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2853231430053711},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2279641032218933},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.20670384168624878},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.12293082475662231}],"mesh":[{"descriptor_ui":"D000071185","descriptor_name":"Pharmacogenomic Testing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010974","descriptor_name":"Platelet Aggregation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011110","descriptor_name":"Polymorphism, Genetic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013928","descriptor_name":"Thromboxane A2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013930","descriptor_name":"Thromboxane-A Synthase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D013930","descriptor_name":"Thromboxane-A Synthase","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D013930","descriptor_name":"Thromboxane-A Synthase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D044244","descriptor_name":"Receptors, Thromboxane A2, Prostaglandin H2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.2174/1871525716666180724115132","doi":"https://doi.org/10.2174/1871525716666180724115132","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1871525716666180724115132","pdf_url":null,"source":{"id":"https://openalex.org/S2764933655","display_name":"Cardiovascular & Hematological Agents in Medicinal Chemistry","issn_l":"1871-5257","issn":["1871-5257","1875-6182"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","medline","norway-1","poland-20","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular & Hematological Agents in Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:30039765","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30039765","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular & hematological agents in medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9922999739646912,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2121918345","https://openalex.org/W153423633","https://openalex.org/W2156073353","https://openalex.org/W2142310801","https://openalex.org/W2917508072","https://openalex.org/W2394604452","https://openalex.org/W2026967478","https://openalex.org/W2335075972","https://openalex.org/W2003904814","https://openalex.org/W1986342394"],"abstract_inverted_index":{"Atherothrombosis-related":[0],"diseases":[1],"are":[2,78],"one":[3],"of":[4,9,51,87,94],"the":[5,13,49,52,67,85],"world\u2019s":[6],"leading":[7],"causes":[8],"mortality,":[10],"and":[11,40,70,81],"thus":[12],"search":[14],"for":[15],"new":[16,80],"therapeutic":[17,42],"approaches":[18],"in":[19,75,84],"this":[20,76],"area":[21,77],"remains":[22],"a":[23],"very":[24],"urgent":[25],"task.":[26],"Modern":[27],"pharmacogenomic":[28],"technologies":[29],"make":[30],"it":[31],"possible":[32],"to":[33],"obtain":[34],"valuable":[35],"data":[36],"on":[37],"disease":[38],"pathogenesis":[39],"optimal":[41],"approaches.":[43],"One":[44],"promising":[45,82],"research":[46],"direction":[47],"is":[48],"study":[50],"thromboxane":[53,56,60,95,98],"A2":[54,61],"-":[55,59],"A":[57,99],"synthase":[58],"receptor":[62],"axis.":[63],"This":[64],"review":[65],"summarizes":[66],"recent":[68],"evidence":[69],"suggests":[71],"that":[72],"systematic":[73],"works":[74],"creating":[79],"opportunities":[83],"treatment":[86],"patients":[88],"with":[89],"cardiovascular":[90,102],"diseases.":[91],"Keywords:":[92],"Inhibitors":[93],"A2-synthase,":[96],"pharmacogenetics,":[97],"synthase,":[100],"thromboxane,":[101],"diseases,":[103],"prostaglandins.":[104]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2018-08-03T00:00:00"}